Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | USP2 | O75604 | 2/20 | 0.45 |
| ▸ | CFTR | P13569 | 1/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12324196 | 0.89 | ABCB1 (0.44) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL19846795 | 0.88 | ABCB1 (0.53) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL26505115 | 0.86 | ABCB1 (0.40) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL20281372 | 0.83 | ABCB1 (0.40) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL20362560 | 0.83 | ABCB1 (0.40) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL15999601 | 0.79 | ABCB1 (0.40) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL21648602 | 0.79 | AR (0.35) | ABCB1PRKDCKDM4EMAPTNPSR1 | |
| SCHEMBL21165046 | 0.78 | USP2 (0.35) | ABCB1USP2CFTRPAX8ATM | |
| SCHEMBL21648600 | 0.78 | MEN1 (0.43) | USP2ATMPRKDCRECQL | |
| Hydrochloric Acid SCHEMBL15992984 | 0.78 | ABCB1 (0.40) | ABCB1USP2CFTRPAX8ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7828858-B2 | Mixture of sulfide dyes | CIBA CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| US-7704284-B2 | Xanthene dyes | CIBA CORPORATION (US) | 2010-04-27 | — | — | US | disclosed |
| US-20090265866-A1 | Xanthene Dyes | CIBA CORP. | 2009-10-29 | — | — | US | disclosed |
| US-20090100610-A1 | Mixture of Sulfide Dyes | CIBA CORPORATION | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090265866-A1 | Xanthene Dyes | KRT18, OR10J3, H1-10 | ABCB1 1892/4885USP2 3475/4885CFTR 2226/4885 |
| US-20090100610-A1 | Mixture of Sulfide Dyes | KRT18, TST, ARSA | ABCB1 2899/4885USP2 2542/4885CFTR 3556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.